Summary
M2 EQUITYBITES-June 3, 2011-Teva Pharmaceutical Industries Ltd enrols patient in Phase III study of 40mg COPAXONE for multiple sclerosis
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Study of 40mg Copaxone for Multiple Sclerosis
Pharmaceutical company Teva Pharmaceutical ...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
Councillor Goes to Seed ; News Brief | Vintage Sale to Aid Homeless | Housing Group Will Decide On Partner | police, camera, action! 9pm, itv1 [...] | U.S District Court THREATS. | Electronic Arts CFO to Speak at the Credit Suisse First Boston Annual Technolog... | iBundle[TM]: fast, secure, and hassle-free. | hcl announces new power architecture tm design center hcl to provide power architecture based system solutions to oems.
